Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000228065

Medchemexpress LLC mTOR inhibitor WYE-23 | 1062169-46-3 | 99.2% | 520.58 g·mol⁻1 | C26H32N8O4 | 25 MG
SDP

Catalog No. 5000228065
Encompass_Preferred

WYE-23 is a potent small-molecule inhibitor of the mechanistic target of rapamycin (mTOR) with reported sub-nanomolar potency and antitumor activity. It shows moderate selectivity versus PI3Kα and is supplied as a research-grade reagent for in vitro and in vivo studies.

  • Potent mTOR inhibition (IC50 0.45 nM).
  • Selective versus PI3Kα (IC50 661 nM).
  • Reported antitumor activity in preclinical studies.
  • Molecular weight 520.58 g·mol⁻1; chemical formula C26H32N8O4.
  • High purity (≈99%).
  • Recommended storage: powder at -20°C; in solvent store at -80°C (6 months) or -20°C (1 month).

Catalog No. 50-002-28065 Supplier Medchemexpress LLC Supplier No. HY11871225MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

WYE-23 is a potent small-molecule inhibitor of the mechanistic target of rapamycin (mTOR) with reported sub-nanomolar potency and antitumor activity. It shows moderate selectivity versus PI3Kα and is supplied as a research-grade reagent for in vitro and in vivo studies.

  • Potent mTOR inhibition (IC50 0.45 nM).
  • Selective versus PI3Kα (IC50 661 nM).
  • Reported antitumor activity in preclinical studies.
  • Molecular weight 520.58 g·mol⁻1; chemical formula C26H32N8O4.
  • High purity (≈99%).
  • Recommended storage: powder at -20°C; in solvent store at -80°C (6 months) or -20°C (1 month).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.